Olympus Thunderbeat Surgical Device Recalled Due to Adverse Events
Firm is initiating a removal due to continued reports of adverse events.
Recall database
Firm is initiating a removal due to continued reports of adverse events.
Firm is initiating a removal due to continued reports of adverse events.
Firm is initiating a removal due to continued reports of adverse events.
Firm is initiating a removal due to continued reports of adverse events.
Firm is initiating a removal due to continued reports of adverse events.
Olympus Corporation of the Americas recalled 140 units of its Thunderbeat surgical device on October 22, 2025. Users reported ongoing adverse events linked to the device. Healthcare providers should stop using it immediately and follow recall instructions.
Firm is initiating a removal due to continued reports of adverse events.
Firm is initiating a removal due to continued reports of adverse events.
Lack of Assurance of Sterility.
Mindray DS USA recalled 148 Sevoflurane V90 electronic vaporizers used with the A9 Anesthesia System. The devices have a potential for anesthesia leakage. Healthcare facilities should stop using the device immediately and follow manufacturer instructions.
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
The possibility for this product that is intended for demonstration purposes only to be placed in patients.
Product found to contain leachable lead levels.
Elevated levels of lead. FDA ground cinnamon sample was found to contain 2.92 mg/kg.
Cooked egg ingredient for Ready-to-Eat products tested positive for Listeria Monocytogenes


